Position in VCYT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,206,720
+$1,039,752 QoQ
Shares Held
37,574
+3.7% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#123
of 367 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 12%
Shared 88%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026VIRTUS ADVISERS, LLC holds $5,478,670 across 8 Diagnostics & Research names. VCYT ranks #1 (40.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCYT |
Veracyte, Inc.
This page
|
37,574 | $2,206,720 | |
| 2 | CDNA |
CareDx, Inc.
|
42,046 | $1,198,311 | |
| 3 | NTRA |
Natera, Inc.
|
3,741 | $1,015,493 | |
| 4 | TWST |
Twist Bioscience Corp
|
4,726 | $486,210 | |
| 5 | GH |
Guardant Health, Inc.
|
2,888 | $433,286 | |
| 6 | MYGN |
Myriad Genetics Inc
|
20,502 | $117,066 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
41 | $21,584 | |
| 8 | ADPT |
Adaptive Biotechnologies Corp
|
4,049 | $0 |
All Filings in VCYT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,206,720 | 37,574 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $1,166,968 | 36,230 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $1,525,282 | 36,230 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,243,775 | 36,230 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $979,296 | 36,230 | Shares | Other | 2026-02-13 | |
| 2025-03-31 | $1,074,218 | 36,230 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||